SREBF1 and metabolic dysfunction-associated steatotic liver disease: Western blot and q-PCR results also showed that emodin downregulated the intracellular protein expression levels of SREBP-1c, ACC1, FASN, and ACLY (Figure 7C–7K), which was in accordance with the effects of PRPM treatment in the livers of the NAFLD model mice.